The evolution in the use of MIBG scintigraphy in pheochromocytomas and paragangliomas

  title={The evolution in the use of MIBG scintigraphy in pheochromocytomas and paragangliomas},
  author={V. Rufini and G. Treglia and G. Perotti and A. Giordano},
  • V. Rufini, G. Treglia, +1 author A. Giordano
  • Published 2013
  • Medicine
  • Hormones
  • Radioiodinated metaiodobenzylguanidine (MIBG) was developed in the late 1970’s, at the Michigan University Medical center, for imaging of the adrenal medulla and its diseases. Soon after, MIBG was shown to depict a wide range of tumors of neural crest origin other than pheochromocytomas/paragangliomas (Pheo/PGL) with the result that its use rapidly spread to many countries. After more than 30 years of clinical application, MIBG continues to be the most widespread radiopharmaceutical for the… CONTINUE READING
    13 Citations
    Utility of 123I-MIBG Standardized Uptake Value in Patients with Refractory Pheochromocytoma and Paraganglioma
    Pheochromocytoma: An approach to diagnosis.
    • 3
    FDG-PET and CT findings of activated brown adipose tissue in a patient with paraganglioma
    • 4
    • Highly Influenced
    Therapeutic and diagnostic radiopharmaceuticals
    • 1
    • PDF


    The evolution in the use of MIBG in more than 25 years of experimental and clinical applications.
    • V. Rufini, B. Shulkin
    • Medicine
    • The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
    • 2008
    • 22
    Scintigraphic localization of pheochromocytoma.
    • 496
    PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma.
    • 155
    Radiopharmaceutical treatment of malignant pheochromocytoma.
    • 193
    Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma.
    • 90
    Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues.
    • 136
    A meta-iodobenzylguanidine scintigraphic scoring system increases accuracy in the diagnostic management of pheochromocytoma.
    • 21
    • PDF
    Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma.
    • 126
    123I-meta-iodobenzylguanidine scintigraphy for the detection of neuroblastoma and pheochromocytoma: results of a meta-analysis.
    • 117
    • PDF
    Current role of metaiodobenzylguanidine in the diagnosis of pheochromocytoma and medullary thyroid cancer.
    • 41